Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Journal of Alzheimer'S Disease : JAD
|
November 13, 2013
An intensive exercise program improves motor performances in patients with dementia: translational model of geriatric rehabilitation
Michael Schwenk, Ilona Dutzi, Stefan Englert, et al.
Pharmaceutical Statistics
|
February 12, 2026
Evaluating Safety Rules in Ongoing Dose-Escalation Trials Using BOIN: A Comparative Analysis of Criteria and Their Impact on Dose-Level Safety Assessments
Stefan Englert, Thomas J Prior, Anirban Mitra, et al.
Pharmaceutical Statistics
|
August 14, 2024
Principles for Defining Estimands in Clinical Trials-A Proposal
Tobias Mütze, James Bell, Stefan Englert, et al.
Acta Ophthalmologica
|
November 21, 2012
Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis
Bianca C Dobner, Aline I Riechardt, Antonia M Joussen, et al.
Pharmaceutical Statistics
|
July 5, 2023
Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development
Stefan Englert, François Mercier, Elizabeth A Pilling, et al.
Annals of Surgical Oncology
|
December 25, 2012
Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study
Christoph Domschke, Ingo J Diel, Stefan Englert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 1, 2015
Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease
Sebastian Mueller, Stefan Englert, Helmut K Seitz, et al.
Plos One
|
September 27, 2013
Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases
Arthur Liesz, Holger Rüger, Jan Purrucker, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework
Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 16, 2022
Association of Baseline and Pharmacodynamic Biomarkers With Outcomes in Patients Treated With the PD-1 Inhibitor Budigalimab
Stacie L Lambert, Chun Zhang, Claire Guo, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Journal of Alzheimer'S Disease : JAD
|
November 13, 2013
An intensive exercise program improves motor performances in patients with dementia: translational model of geriatric rehabilitation
Michael Schwenk, Ilona Dutzi, Stefan Englert, et al.
Pharmaceutical Statistics
|
February 12, 2026
Evaluating Safety Rules in Ongoing Dose-Escalation Trials Using BOIN: A Comparative Analysis of Criteria and Their Impact on Dose-Level Safety Assessments
Stefan Englert, Thomas J Prior, Anirban Mitra, et al.
Pharmaceutical Statistics
|
August 14, 2024
Principles for Defining Estimands in Clinical Trials-A Proposal
Tobias Mütze, James Bell, Stefan Englert, et al.
Acta Ophthalmologica
|
November 21, 2012
Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis
Bianca C Dobner, Aline I Riechardt, Antonia M Joussen, et al.
Pharmaceutical Statistics
|
July 5, 2023
Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early development
Stefan Englert, François Mercier, Elizabeth A Pilling, et al.
Annals of Surgical Oncology
|
December 25, 2012
Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study
Christoph Domschke, Ingo J Diel, Stefan Englert, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 1, 2015
Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease
Sebastian Mueller, Stefan Englert, Helmut K Seitz, et al.
Plos One
|
September 27, 2013
Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases
Arthur Liesz, Holger Rüger, Jan Purrucker, et al.
Statistics in Biopharmaceutical Research
|
June 30, 2021
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework
Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
January 16, 2022
Association of Baseline and Pharmacodynamic Biomarkers With Outcomes in Patients Treated With the PD-1 Inhibitor Budigalimab
Stacie L Lambert, Chun Zhang, Claire Guo, et al.
Page
of 3